SI1304107T1 - Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze - Google Patents
Uporaba oksazolidinonskih derivatov za zdravljenje psoriazeInfo
- Publication number
- SI1304107T1 SI1304107T1 SI9830786T SI9830786T SI1304107T1 SI 1304107 T1 SI1304107 T1 SI 1304107T1 SI 9830786 T SI9830786 T SI 9830786T SI 9830786 T SI9830786 T SI 9830786T SI 1304107 T1 SI1304107 T1 SI 1304107T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oxazolidinines
- derivatives
- treating psoriasis
- psoriasis
- treating
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- 229940030999 antipsoriatics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6568997P | 1997-11-18 | 1997-11-18 | |
US7129798P | 1998-01-16 | 1998-01-16 | |
US7524798P | 1998-02-19 | 1998-02-19 | |
EP02028171A EP1304107B1 (en) | 1997-11-18 | 1998-11-10 | Use of oxazolidinines derivatives for treating psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1304107T1 true SI1304107T1 (sl) | 2005-10-31 |
Family
ID=34743570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9830786T SI1304107T1 (sl) | 1997-11-18 | 1998-11-10 | Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1304107B1 (sl) |
AT (1) | ATE299021T1 (sl) |
DE (1) | DE69830811T2 (sl) |
DK (1) | DK1304107T3 (sl) |
ES (1) | ES2243650T3 (sl) |
PT (1) | PT1304107E (sl) |
SI (1) | SI1304107T1 (sl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11608320B2 (en) | 2020-02-02 | 2023-03-21 | Kuwait University | Oxazolidinone hydroxamic acid derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0610265B1 (en) * | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
CN1046276C (zh) * | 1993-11-22 | 1999-11-10 | 法玛西雅厄普约翰美国公司 | 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途 |
-
1998
- 1998-11-10 SI SI9830786T patent/SI1304107T1/sl unknown
- 1998-11-10 EP EP02028171A patent/EP1304107B1/en not_active Expired - Lifetime
- 1998-11-10 PT PT02028171T patent/PT1304107E/pt unknown
- 1998-11-10 ES ES02028171T patent/ES2243650T3/es not_active Expired - Lifetime
- 1998-11-10 DE DE69830811T patent/DE69830811T2/de not_active Expired - Fee Related
- 1998-11-10 DK DK02028171T patent/DK1304107T3/da active
- 1998-11-10 AT AT02028171T patent/ATE299021T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69830811D1 (de) | 2005-08-11 |
ATE299021T1 (de) | 2005-07-15 |
DE69830811T2 (de) | 2006-04-27 |
DK1304107T3 (da) | 2005-08-22 |
EP1304107B1 (en) | 2005-07-06 |
EP1304107A2 (en) | 2003-04-23 |
EP1304107A3 (en) | 2003-11-19 |
PT1304107E (pt) | 2005-09-30 |
ES2243650T3 (es) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW249226B (sl) | ||
HU912359D0 (en) | The use of flupirtine active agents for treating muscle-tension | |
EP0102534A3 (en) | Hair-growing agent | |
EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
NO944339L (no) | Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser | |
NO944340D0 (no) | Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander | |
SI1304107T1 (sl) | Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze | |
SI1032386T1 (sl) | Uporaba oksazolidinonskih derivatov za zdravljenje artritisa | |
UA29461C2 (uk) | Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу | |
SI0836853T1 (sl) | Uporaba bradikininskih antagonistov za pripravo zdravil za zdravljenje in preprečevanje Alzheimerjeve bolezni | |
DE59813136D1 (de) | Verwendung von Thiaminen zur Herstellung eines Arzneimittels zur Prophylaxe und zur Therapie der diabetischen Retinopathie und der diabetischen Nephropathie |